8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 24, 2026·SEC
Material company update
Mar 3, 2026·SEC
Select Medical Holdings Corporation(SEM)Earnings, Financials & Key Ratios
SEM•NYSE
14.0× P/E·Price updated Jun 19, 2026
AboutSelect Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.Show more
- Revenue$5.45B+5.1%
- EBITDA$475M+0.6%
- Net Income$146M-31.7%
- EPS (Diluted)1.18-28.9%
- Gross Margin11.54%-5.5%
- EBITDA Margin8.71%-4.3%
- Operating Margin6.14%+18.6%
- Net Margin2.68%-35.0%
- ROE7.25%-39.5%
SEM Key Insights
Select Medical Holdings Corporation (SEM) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Trading near 52-week high
- ✓Trading at only 1.0x book value
✗Weaknesses
- ✗Profits declining 10.8% over 5 years
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SEM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SEM Price & Volume
Select Medical Holdings Corporation (SEM) stock price & volume — 10-year historical chart
Loading chart...
SEM Growth Metrics
Select Medical Holdings Corporation (SEM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years3.83%
5 Years-0.29%
3 Years-4.87%
TTM29.19%
Profit CAGR
10 Years1.13%
5 Years-10.8%
3 Years-2.75%
TTM-23.18%
EPS CAGR
10 Years1.77%
5 Years-9.37%
3 Years-1.37%
TTM-19.26%
Return on Capital
10 Years7.95%
5 Years7.69%
3 Years6.82%
Last Year7.05%
SEM Recent Earnings
Select Medical Holdings Corporation (SEM) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$0.36-16.3%
$0.43
Rev
$1.4B+0.7%
$1.4B
Q1 2026
Feb 19, 2026Metric
Actual
Est
EPS
$0.16-30.4%
$0.23
Rev
$1.4B+2.4%
$1.4B
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$0.23+27.8%
$0.18
Rev
$1.4B-0.0%
$1.4B
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.32+14.3%
$0.28
Rev
$1.3B+0.4%
$1.3B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.36vs $0.43-16.3% | $1.4Bvs $1.4B+0.7% |
| Q1 2026 | Feb 19, 2026 | $0.16vs $0.23-30.4% | $1.4Bvs $1.4B+2.4% |
| Q4 2025 | Oct 30, 2025 | $0.23vs $0.18+27.8% | $1.4Bvs $1.4B-0.0% |
| Q3 2025 | Jul 31, 2025 | $0.32vs $0.28+14.3% | $1.3Bvs $1.3B+0.4% |
Based on last 12 quarters of dataView full earnings history →
SEM Peer Comparison
Select Medical Holdings Corporation (SEM) competitors in Post-acute and senior care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 | |
 ACHC | 2.29B | 24.87 | -2.05 | 5.04% | -32.84% | -40.92% | 1.24 | |
 UHS | 8.84B | 141.17 | 6.11 | 9.71% | 8.56% | 20.65% | 0.74 | |
 SGRY | 1.9B | 14.55 | -23.85 | 6.24% | -2.28% | -2.15% | 1.14 | |
 HCA | 83.88B | 375.17 | 13.22 | 7.08% | 8.97% | |||
 THC | 15.12B | 172.57 | 11.14 | 3.12% | 7.94% | 19.56% | 1.47 | |
 CYH | 425.61M | 3.02 | 0.80 | -1.18% | -0.41% | |||
 USPH | 964.39M | 63.32 | 44.59 | 16.33% | 1.52% | 1.36% | 0.55 |
Compare SEM vs Peers
Select Medical Holdings Corporation (SEM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SEM Income Statement
Select Medical Holdings Corporation (SEM) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 4.44B | 5.08B | 5.45B | 5.53B | 6.2B | 6.33B | 6.66B | 5.19B | 5.45B | 5.52B |
Revenue Growth % | 3.68% | 14.35% | 7.33% | 1.43% | 12.16% | 2.08% | 5.22% | -22.16% | 5.12% | 29.19% |
Cost of Goods Sold | 3.73B | 4.34B | 4.64B | 4.71B | 5.29B | 5.6B | 5.73B | 4.55B | 4.82B | 4.93B |
COGS % of Revenue | 84.03% | 85.43% | 85.09% | 85.15% | 85.18% | 88.42% | 86.01% | 87.78% | 88.46% | - |
Gross Profit | 709.43M▲ 0% | 740.2M▲ 4.3% | 812.92M▲ 9.8% | 821.34M▲ 1.0% | 919.37M▲ 11.9% | 733.38M▼ 20.2% | 932.04M▲ 27.1% | 633.64M▼ 32.0% | 629.29M▼ 0.7% | 588M▲ 0% |
Gross Margin % | 15.97% | 14.57% | 14.91% | 14.85% | 14.82% | 11.58% | 13.99% | 12.22% | 11.54% | 10.65% |
Gross Profit Growth % | 14.21% | 4.34% | 9.82% | 1.04% | 11.93% | -20.23% | 27.09% | -32.02% | -0.69% | - |
Operating Expenses | 274.06M | 322.92M | 341.04M | 253.68M | 205.59M | 330.09M | 377.17M | 365.33M | 294.72M | 266.15M |
OpEx % of Revenue | 6.17% | 6.36% | 6.25% | 4.59% | 3.31% | 5.21% | 5.66% | 7.04% | 5.4% | - |
Selling, General & Admin | 114.05M | 121.27M | 128.46M | 138.04M | 146.97M | 153.03M | 170.19M | 225.87M | 154.41M | 160.79M |
SG&A % of Revenue | 2.57% | 2.39% | 2.36% | 2.5% | 2.37% | 2.42% | 2.55% | 4.35% | 2.83% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | -49K | 201.66M | 212.58M | 115.65M | 58.62M | 177.06M | 206.97M | 139.46M | 140.3M | 3M |
Operating Income | 355.88M▲ 0% | 417.28M▲ 17.3% | 471.88M▲ 13.1% | 567.66M▲ 20.3% | 713.77M▲ 25.7% | 403.28M▼ 43.5% | 554.87M▲ 37.6% | 268.31M▼ 51.6% | 334.58M▲ 24.7% | 321.84M▲ 0% |
Operating Margin % | 8.01% | 8.21% | 8.65% | 10.26% | 11.5% | 6.37% | 8.33% | 5.17% | 6.14% | 5.83% |
Operating Income Growth % | 18.69% | 17.25% | 13.09% | 20.3% | 25.74% | -43.5% | 37.59% | -51.64% | 24.7% | - |
EBITDA | 515.89M | 618.93M | 684.46M | 773.32M | 916.42M | 609.11M | 763.62M | 472.21M | 474.88M | 465M |
EBITDA Margin % | 11.61% | 12.18% | 12.55% | 13.98% | 14.77% | 9.62% | 11.46% | 9.1% | 8.71% | 8.42% |
EBITDA Growth % | 15.89% | 19.97% | 10.59% | 12.98% | 18.51% | -33.53% | 25.37% | -38.16% | 0.57% | 61.58% |
D&A (Non-Cash Add-back) | 160.01M | 201.66M | 212.58M | 205.66M | 202.65M | 205.82M | 208.74M | 203.89M | 140.3M | 143.16M |
EBIT | 357.16M | 420.17M | 465.32M | 477.64M | 765.71M | 429.69M | 581M | 303.37M | 390.33M | 265.07M |
Net Interest Income | -154.7M | -198.49M | -200.57M | -153.01M | -130.63M | -169.11M | -198.64M | -128.6M | -117.58M | -88.51M |
Interest Income | 0 | 0 | 0 | 0 | 5.35M | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 154.7M | 198.49M | 200.57M | 153.01M | 135.99M | 169.11M | 198.64M | 128.6M | 117.58M | 60.17M |
Other Income/Expense | -153.42M | -181.73M | -207.13M | -111.18M | -84.05M | -142.7M | -172.52M | -93.55M | -61.83M | -63.19M |
Pretax Income | 202.46M▲ 0% | 235.55M▲ 16.3% | 264.75M▲ 12.4% | 456.47M▲ 72.4% | 629.72M▲ 38.0% | 260.58M▼ 58.6% | 382.36M▲ 46.7% | 174.77M▼ 54.3% | 272.75M▲ 56.1% | 258.66M▲ 0% |
Pretax Margin % | 4.56% | 4.64% | 4.85% | 8.25% | 10.15% | 4.11% | 5.74% | 3.37% | 5% | 4.68% |
Income Tax | -18.18M | 58.61M | 63.72M | 111.87M | 129.77M | 62.55M | 82.63M | 44.78M | 58.22M | 55.08M |
Effective Tax Rate % | -8.98% | 24.88% | 24.07% | 24.51% | 20.61% | 24.01% | 21.61% | 25.62% | 21.34% | 21.29% |
Net Income | 177.18M▲ 0% | 137.84M▼ 22.2% | 148.45M▲ 7.7% | 259M▲ 74.5% | 402.23M▲ 55.3% | 158.99M▼ 60.5% | 243.49M▲ 53.1% | 214.04M▼ 12.1% | 146.22M▼ 31.7% | 133.53M▲ 0% |
Net Margin % | 3.99% | 2.71% | 2.72% | 4.68% | 6.48% | 2.51% | 3.65% | 4.13% | 2.68% | 2.42% |
Net Income Growth % | 53.52% | -22.21% | 7.7% | 74.47% | 55.3% | -60.47% | 53.14% | -12.1% | -31.69% | -23.18% |
Net Income (Continuing) | 220.65M | 176.94M | 201.03M | 344.61M | 499.95M | 198.03M | 299.73M | 129.99M | 214.53M | 183.8M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 166.72M | 0 | 0 |
Minority Interest | 109.24M | 113.2M | 1.13B | 590.66M | 254.95M | 268.69M | 285.71M | 315.74M | 330.15M | 20.97M |
EPS (Diluted) | 0.87▲ 0% | 1.06▲ 21.8% | 1.54▲ 45.3% | 1.93▲ 25.3% | 2.99▲ 54.9% | 1.23▼ 58.9% | 1.91▲ 55.3% | 1.66▼ 13.1% | 1.18▼ 28.9% | 1.08▲ 0% |
EPS Growth % | 0% | 21.84% | 45.28% | 25.32% | 54.92% | -58.86% | 55.28% | -13.09% | -28.92% | -19.26% |
EPS (Basic) | 1.33 | 1.06 | 1.54 | 1.93 | 2.99 | 1.23 | 1.91 | 1.66 | 1.18 | - |
Diluted Shares Outstanding | 129.13M | 130.26M | 130.28M | 129.78M | 130.25M | 124.63M | 123.11M | 124.61M | 123.51M | 123.51M |
Basic Shares Outstanding | 128.96M | 130.17M | 130.25M | 129.78M | 130.25M | 124.63M | 123.11M | 129.19M | 123.51M | 123.51M |
Dividend Payout Ratio | - | - | - | - | 12.58% | 40.62% | 26.24% | 30.19% | 21.5% | - |
SEM Balance Sheet
Select Medical Holdings Corporation (SEM) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 920.83M | 992.52M | 1.21B | 1.59B | 1.14B | 1.27B | 1.26B | 1.02B | 1.03B | 1.11B |
Cash & Short-Term Investments | 122.55M | 175.18M | 335.88M | 577.06M | 74.31M | 172.76M | 111.59M | 59.69M | 26.52M | 25.68M |
Cash Only | 122.55M | 175.18M | 335.88M | 577.06M | 74.31M | 97.91M | 52.63M | 59.69M | 26.52M | 25.68M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 74.86M | 58.96M | 0 | 0 | 0 |
Accounts Receivable | 691.73M | 706.68M | 768.38M | 896.76M | 889.3M | 941.31M | 724.14M | 821.38M | 864.21M | 949.48M |
Days Sales Outstanding | 56.82 | 50.76 | 51.42 | 59.17 | 52.32 | 54.25 | 39.66 | 57.8 | 57.85 | 58.66 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
Other Current Assets | 106.55M | 110.67M | 90.15M | 114.49M | 120.21M | 125.37M | 407.16M | 138.7M | 134.55M | 136.93M |
Total Non-Current Assets | 4.21B | 4.97B | 6.13B | 6.06B | 6.22B | 6.39B | 6.43B | 4.59B | 4.83B | 4.93B |
Property, Plant & Equipment | 912.59M | 979.81M | 2B | 1.98B | 2.04B | 2.17B | 1.64B | 1.78B | 1.95B | 2.04B |
Fixed Asset Turnover | 4.87x | 5.19x | 2.72x | 2.80x | 3.04x | 2.92x | 4.07x | 2.91x | 2.80x | 2.87x |
Goodwill | 2.78B | 3.32B | 3.39B | 3.38B | 3.45B | 3.48B | 2.28B | 2.33B | 2.36B | 2.38B |
Intangible Assets | 326.52M | 437.69M | 409.07M | 387.54M | 374.88M | 351.66M | 105.15M | 103.18M | 100.8M | 99.86M |
Long-Term Investments | 114.2M | 146.9M | 28.7M | 2.5M | 18.05M | 45.2M | 0 | 320.9M | 346.4M | 346.4M |
Other Non-Current Assets | 184.42M | 233.51M | 295.18M | 316.71M | 338.67M | 341.74M | 2.41B | 51.91M | 67.99M | 412.31M |
Total Assets | 5.13B▲ 0% | 5.96B▲ 16.3% | 7.34B▲ 23.1% | 7.66B▲ 4.3% | 7.36B▼ 3.9% | 7.67B▲ 4.1% | 7.69B▲ 0.3% | 5.61B▼ 27.1% | 5.85B▲ 4.3% | 6.04B▲ 0% |
Asset Turnover | 0.87x | 0.85x | 0.74x | 0.72x | 0.84x | 0.83x | 0.87x | 0.92x | 0.93x | 0.95x |
Asset Growth % | 3.7% | 16.33% | 23.07% | 4.29% | -3.86% | 4.15% | 0.32% | -27.07% | 4.34% | -45.62% |
Total Current Liabilities | 605.4M | 705.19M | 914.28M | 1.44B | 1.27B | 1.16B | 1.25B | 977.65M | 984.49M | 970.37M |
Accounts Payable | 128.19M | 146.69M | 145.73M | 177.09M | 233.84M | 186.73M | 153.9M | 142.16M | 157.06M | 166.47M |
Days Payables Outstanding | 12.53 | 12.33 | 11.46 | 13.72 | 16.15 | 12.17 | 9.8 | 11.4 | 11.89 | 12.1 |
Short-Term Debt | 51.65M | 68.95M | 233.12M | 233.03M | 59.92M | 76.31M | 99.15M | 46.07M | 229.37M | 204.63M |
Deferred Revenue (Current) | 29.46M | 25.08M | 0 | 0 | 83.79M | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 255.93M | 313.49M | 224.93M | 662.6M | 0 | 0 | 271.28M | 0 | 596.83M | 599.26M |
Current Ratio | 1.52x | 1.41x | 1.33x | 1.11x | 0.90x | 1.10x | 1.01x | 1.04x | 1.04x | 1.15x |
Quick Ratio | 1.52x | 1.41x | 1.33x | 1.11x | 0.90x | 1.10x | 1.01x | 1.04x | 1.04x | 1.15x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | 46.56 |
Total Non-Current Liabilities | 3.59B | 4.34B | 4.52B | 4.57B | 4.72B | 5.12B | 4.87B | 2.63B | 2.83B | 2.97B |
Long-Term Debt | 2.68B | 3.25B | 3.42B | 3.39B | 3.56B | 3.84B | 3.58B | 1.69B | 2.57B | 931.2M |
Capital Lease Obligations | 0 | 0 | 852.9M | 875.37M | 916.54M | 1.01B | 668.56M | 797.14M | 900.71M | 2.54B |
Deferred Tax Liabilities | 124.92M | 153.9M | 148.26M | 132.42M | 142.79M | 169.79M | 119.94M | 81.5M | 112.16M | 391.28M |
Other Non-Current Liabilities | 145.71M | 158.94M | 101.33M | 168.7M | 106.44M | 106.14M | 494.27M | 73.04M | -755.5M | 1.92B |
Total Liabilities | 4.19B | 5.05B | 5.44B | 6B | 6B | 6.27B | 6.12B | 3.61B | 3.82B | 3.94B |
Total Debt | 2.7B | 3.29B | 4.51B | 4.5B | 4.76B | 5.16B | 4.52B | 2.7B | 3.7B | 1.14B |
Net Debt | 2.58B | 3.12B | 4.17B | 3.92B | 4.69B | 5.06B | 4.47B | 2.64B | 3.68B | 1.11B |
Debt / Equity | 2.59x | 3.20x | 2.37x | 2.72x | 3.49x | 3.71x | 2.87x | 1.35x | 1.82x | 0.54x |
Debt / EBITDA | 5.23x | 5.32x | 6.58x | 5.82x | 5.20x | 8.47x | 5.93x | 5.73x | 7.80x | 2.44x |
Net Debt / EBITDA | 5.00x | 5.04x | 6.09x | 5.07x | 5.12x | 8.31x | 5.86x | 5.60x | 7.74x | 2.39x |
Interest Coverage | 2.31x | 2.12x | 2.32x | 3.12x | 5.63x | 2.54x | 2.92x | 2.36x | 3.32x | 4.41x |
Total Equity | 1.04B▲ 0% | 1.03B▼ 1.2% | 1.9B▲ 84.9% | 1.65B▼ 13.3% | 1.36B▼ 17.3% | 1.39B▲ 1.9% | 1.57B▲ 13.2% | 2B▲ 26.9% | 2.04B▲ 1.9% | 2.08B▲ 0% |
Equity Growth % | 4.59% | -1.19% | 84.91% | -13.26% | -17.33% | 1.88% | 13.19% | 26.88% | 1.93% | 6.39% |
Book Value per Share | 8.07 | 7.90 | 14.61 | 12.72 | 10.48 | 11.16 | 12.79 | 16.03 | 16.48 | 16.88 |
Total Shareholders' Equity | 932.6M | 916.24M | 770.97M | 1.06B | 1.11B | 1.12B | 1.29B | 1.68B | 1.71B | 1.76B |
Common Stock | 134K | 135K | 134K | 135K | 134K | 127K | 128K | 129K | 124K | 124K |
Retained Earnings | 359.74M | 320.35M | 279.8M | 553.24M | 593.25M | 581.01M | 751.86M | 770.15M | 837.02M | 872.22M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -630.66M | -764.58M | 0 | -2.03M | 12.28M | 88.6M | 42.91M | 0 | -6.4M | -5.38M |
Minority Interest | 109.24M | 113.2M | 1.13B | 590.66M | 254.95M | 268.69M | 285.71M | 315.74M | 330.15M | 20.97M |
SEM Cash Flow Statement
Select Medical Holdings Corporation (SEM) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 238.13M | 494.19M | 445.18M | 1.03B | 401.23M | 284.82M | 582.06M | 517.86M | 346.47M | 346.47M |
Operating CF Margin % | 5.36% | 9.73% | 8.16% | 18.59% | 6.47% | 4.5% | 8.73% | 9.98% | 6.35% | - |
Operating CF Growth % | -31.3% | 107.53% | -9.92% | 130.93% | -60.97% | -29.01% | 104.36% | -11.03% | -33.1% | -112.19% |
Net Income | 220.65M | 176.94M | 201.03M | 344.61M | 499.95M | 198.03M | 299.73M | 296.7M | 146.22M | 133.53M |
Depreciation & Amortization | 160.01M | 201.66M | 212.58M | 205.66M | 202.65M | 205.82M | 208.74M | 203.89M | 140.3M | 140.3M |
Stock-Based Compensation | 19.28M | 23.33M | 26.45M | 27.25M | 30.94M | 37.76M | 43.81M | 100.67M | 16.7M | 12.18M |
Deferred Taxes | -72.32M | 7.22M | -7.43M | -14.71M | 5.05M | 7.52M | -16.12M | -32.43M | 30.65M | 30.65M |
Other Non-Cash Items | 85.75M | 656K | 25.65M | -13.82M | -7.38M | -4.76M | -13.6M | 4.17M | 72.27M | 147.81M |
Working Capital Changes | -175.24M | 84.4M | -13.09M | 479.1M | -329.98M | -159.54M | 59.5M | -55.14M | -59.68M | -180.82M |
Change in Receivables | -197.19M | 54.58M | -57.99M | -116.6M | 23.1M | -52.18M | 1.16M | -95.84M | -45.19M | -45.19M |
Change in Inventory | 1.6M | 0 | 0 | 167.65M | -82.77M | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 21.24M | 26.12M | 5.74M | 27.32M | 53.39M | -48.04M | -6.41M | -16.79M | -854K | -854K |
Cash from Investing | -192.97M | -697.14M | -316.73M | -115.35M | -256.59M | -226.34M | -268.48M | -231.01M | -216.49M | -213.55M |
Capital Expenditures | -233.24M | -167.28M | -157.13M | -146.44M | -180.54M | -190.37M | -229.2M | -222.18M | 36.27M | -229.22M |
CapEx % of Revenue | 5.25% | 3.29% | 2.88% | 2.65% | 2.91% | 3.01% | 3.44% | 4.28% | 0.67% | 4.15% |
Acquisitions | -40.07M | -536.62M | -159.79M | -52.23M | -102.88M | -44.31M | -39.44M | -13.1M | -9.2M | -6.45M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 80.35M | 6.76M | 192K | 83.32M | 26.82M | 8.34M | 163K | 4.26M | -243.56M | 22.13M |
Cash from Financing | -21.65M | 255.57M | 32.25M | -671.54M | -647.38M | -34.89M | -327.48M | -311.17M | -163.15M | -166.09M |
Debt Issued (Net) | -18.27M | 570.92M | 73.46M | -48.12M | 195.7M | 264.68M | -203.95M | -493.46M | 42.34M | 37.45M |
Equity Issued (Net) | -4.75M | -6.84M | -38.53M | -16.03M | -79.48M | -195.53M | -12.76M | 473.29M | -100.08M | -100.08M |
Dividends Paid | 0 | 0 | 0 | 0 | -50.6M | -64.59M | -63.9M | -64.62M | -31.43M | -31.43M |
Share Repurchases | -4.75M | -6.84M | -38.53M | -16.03M | -79.48M | -195.53M | -12.76M | -37.91M | -100.08M | -100.08M |
Other Financing | 1.38M | -308.51M | -2.68M | -607.39M | -713.01M | -39.45M | -46.86M | -226.38M | -73.98M | -72.03M |
Net Change in Cash | 23.52M▲ 0% | 52.63M▲ 123.8% | 160.7M▲ 205.4% | 241.18M▲ 50.1% | -502.75M▼ 308.5% | 23.6M▲ 104.7% | -13.9M▼ 158.9% | -24.31M▼ 74.9% | -33.17M▼ 36.4% | -33.17M▲ 0% |
Free Cash Flow | 4.89M▲ 0% | 326.91M▲ 6588.1% | 288.06M▼ 11.9% | 881.63M▲ 206.1% | 220.69M▼ 75.0% | 94.45M▼ 57.2% | 352.86M▲ 273.6% | 539.65M▲ 52.9% | 382.74M▼ 29.1% | 117.24M▲ 0% |
FCF Margin % | 0.11% | 6.43% | 5.28% | 15.94% | 3.56% | 1.49% | 5.29% | 10.4% | 7.02% | 2.12% |
FCF Growth % | -97.36% | 6588.07% | -11.89% | 206.06% | -74.97% | -57.2% | 273.58% | 52.94% | -29.08% | -67.35% |
FCF per Share | 0.04 | 2.51 | 2.21 | 6.79 | 1.69 | 0.76 | 2.87 | 4.33 | 3.10 | 0.95 |
FCF Conversion (FCF/Net Income) | 1.34x | 3.59x | 3.00x | 3.97x | 1.00x | 1.79x | 2.39x | 2.42x | 2.37x | 0.88x |
Interest Paid | 149.16M | 193.41M | 182.99M | 155.24M | 132.2M | 183.45M | 272.26M | 256.23M | 0 | 38.29M |
Taxes Paid | 64.99M | 48.15M | 70.59M | 108.89M | 181.18M | 32.29M | 88.51M | 133.19M | 0 | 19.58M |
SEM Key Ratios
Select Medical Holdings Corporation (SEM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 17.39% | 13.31% | 10.12% | 14.57% | 26.67% | 11.54% | 16.43% | 11.99% | 7.25% | 6.57% |
Return on Invested Capital (ROIC) | 7.36% | 8.06% | 6.93% | 7.31% | 9.21% | 4.84% | 6.66% | 3.77% | 4.85% | 5.78% |
Gross Margin | 15.97% | 14.57% | 14.91% | 14.85% | 14.82% | 11.58% | 13.99% | 12.22% | 11.54% | 10.65% |
Net Margin | 3.99% | 2.71% | 2.72% | 4.68% | 6.48% | 2.51% | 3.65% | 4.13% | 2.68% | 2.42% |
Debt / Equity | 2.59x | 3.20x | 2.37x | 2.72x | 3.49x | 3.71x | 2.87x | 1.35x | 1.82x | 0.54x |
Interest Coverage | 2.31x | 2.12x | 2.32x | 3.12x | 5.63x | 2.54x | 2.92x | 2.36x | 3.32x | 4.41x |
FCF Conversion | 1.34x | 3.59x | 3.00x | 3.97x | 1.00x | 1.79x | 2.39x | 2.42x | 2.37x | 0.88x |
Revenue Growth | 3.68% | 14.35% | 7.33% | 1.43% | 12.16% | 2.08% | 5.22% | -22.16% | 5.12% | 29.19% |
Related:SEM Dividend History·SEM Revenue History·SEM Price History·SEM P/E History·SEM Financial Ratios·SEM Institutional Holders
SEM SEC Filings & Documents
Select Medical Holdings Corporation (SEM) SEC filings — annual & quarterly reports (10-K, 10-Q)
SEM Frequently Asked Questions
Select Medical Holdings Corporation (SEM) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Select Medical Holdings Corporation (SEM) reported $5.52B in revenue for fiscal year 2025. This represents a 197% increase from $1.86B in 2005.
Select Medical Holdings Corporation (SEM) grew revenue by 5.1% over the past year. This is steady growth.
Yes, Select Medical Holdings Corporation (SEM) is profitable, generating $133.5M in net income for fiscal year 2025 (2.7% net margin).
Dividend & Returns
Yes, Select Medical Holdings Corporation (SEM) pays a dividend with a yield of 1.54%. This makes it attractive for income-focused investors.
Select Medical Holdings Corporation (SEM) has a return on equity (ROE) of 7.3%. This is below average, suggesting room for improvement.
Select Medical Holdings Corporation (SEM) generated $117.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.